Second, we examined the effects of vildagliptin and M20.7 on mRNA expression levels of inflammation-associated genes, such as S100A8, S100A9, and TNF-α, in human hepatoma HepG2 and monocytic HL-60 cells. Here, S100A9 is linked to hepatocellular carcinoma.